178 related articles for article (PubMed ID: 24983305)
1. Time-dependent specificity of immunopathologic (C4d-CD68) and histologic criteria of antibody-mediated rejection for donor-specific antibodies and allograft dysfunction in heart transplantation.
Yerly P; Rotman S; Nobile A; Aubert V; Tozzi P; Yarol N; Vogt P; Hullin R; Pascual M
Transplantation; 2015 Mar; 99(3):586-93. PubMed ID: 24983305
[TBL] [Abstract][Full Text] [Related]
2. Pathologic classification of antibody-mediated rejection correlates with donor-specific antibodies and endothelial cell activation.
Tible M; Loupy A; Vernerey D; Suberbielle C; Beuscart T; Cazes A; Guillemain R; Amrein C; Pezzella V; Fabiani JN; Nochy D; Hill G; Empana JP; Jouven X; Charron D; Bruneval P; Duong Van Huyen JP
J Heart Lung Transplant; 2013 Aug; 32(8):769-76. PubMed ID: 23856214
[TBL] [Abstract][Full Text] [Related]
3. Donor-specific antibodies: can they predict C4d deposition in pediatric heart recipients?
Peng DM; Law YM; Kemna MS; Warner P; Nelson K; Boucek RJ
Pediatr Transplant; 2013 Aug; 17(5):429-35. PubMed ID: 23551503
[TBL] [Abstract][Full Text] [Related]
4. Reclassification of C4d-Positive Endomyocardial Biopsy (EMB) According to New International Society for Heart and Lung Transplantation (ISHLT) 2013 Categories for Reporting Pathologic Antibody-Mediated Rejection (pAMR): Preliminary Data from a Polish Single-Center Study.
Szymańska S; Grajkowska W; Sobieszczańska-Małek M; Zieliński T; Pronicki M
Ann Transplant; 2015 Jun; 20():351-6. PubMed ID: 26101425
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies.
Cai Q; Moore SA; Hendricks AR; Torrealba JR
Transplant Proc; 2020 May; 52(4):1192-1197. PubMed ID: 32197864
[TBL] [Abstract][Full Text] [Related]
6. C4d analysis in endomyocardial biopsies of heart transplant patients: is there a correlation with hemodynamic data?
Boffini M; Ricci D; Bonato R; Ribezzo M; Simonato E; Saviolo R; Checco L; Comoglio C; Rinaldi M
Transplant Proc; 2011 May; 43(4):1168-70. PubMed ID: 21620080
[TBL] [Abstract][Full Text] [Related]
7. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
Frank R; Dean SA; Molina MR; Kamoun M; Lal P
Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
[TBL] [Abstract][Full Text] [Related]
8. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
9. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients.
Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M
Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967
[TBL] [Abstract][Full Text] [Related]
10. Biopsy-diagnosed antibody-mediated rejection based on the proposed International Society for Heart and Lung Transplantation working formulation is associated with adverse cardiovascular outcomes after pediatric heart transplant.
Everitt MD; Hammond ME; Snow GL; Stehlik J; Revelo MP; Miller DV; Kaza AK; Budge D; Alharethi R; Molina KM; Kfoury AG
J Heart Lung Transplant; 2012 Jul; 31(7):686-93. PubMed ID: 22551931
[TBL] [Abstract][Full Text] [Related]
11. Circulating donor-specific anti-human leukocyte antigen antibodies and complement C4d deposition are associated with the development of cardiac allograft vasculopathy.
Frank R; Molina MR; Goldberg LR; Wald JW; Kamoun M; Lal P
Am J Clin Pathol; 2014 Dec; 142(6):809-15. PubMed ID: 25389335
[TBL] [Abstract][Full Text] [Related]
12. Donor-specific antibodies against HLA, MICA, and GSTT1 in patients with allograft rejection and C4d deposition in renal biopsies.
Alvarez-Márquez A; Aguilera I; Gentil MA; Caro JL; Bernal G; Fernández Alonso J; Acevedo MJ; Cabello V; Wichmann I; Gonzalez-Escribano MF; Núñez-Roldán A
Transplantation; 2009 Jan; 87(1):94-9. PubMed ID: 19136897
[TBL] [Abstract][Full Text] [Related]
13. C4D immunostaining in surveillance endomyocardial biopsies from well-functioning heart allografts.
Arias LF; Fernández R; Fernández D; Jaramillo JC; Gil M; López García-Asenjo JA
Transplant Proc; 2010 Jun; 42(5):1793-6. PubMed ID: 20620525
[TBL] [Abstract][Full Text] [Related]
14. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated allograft rejection: morphologic spectrum and serologic correlations in surveillance and for cause biopsies.
Papadimitriou JC; Drachenberg CB; Ramos E; Kukuruga D; Klassen DK; Ugarte R; Nogueira J; Cangro C; Weir MR; Haririan A
Transplantation; 2013 Jan; 95(1):128-36. PubMed ID: 23222897
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of antibody-mediated rejection in cardiac transplantation: a call for standardization.
Tan CD; Rodriguez ER
Curr Opin Organ Transplant; 2010 Dec; 15(6):769-73. PubMed ID: 20881496
[TBL] [Abstract][Full Text] [Related]
17. Correlation of circulating donor-specific anti-HLA antibodies and presence of C4d in endomyocardial biopsy with heart allograft outcomes: a single-center, retrospective study.
Frank R; Molina MR; Wald JW; Goldberg LR; Kamoun M; Lal P
J Heart Lung Transplant; 2013 Apr; 32(4):410-7. PubMed ID: 23498162
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory cell burden and phenotype in endomyocardial biopsies with antibody-mediated rejection (AMR): a multicenter pilot study from the AECVP.
Fedrigo M; Leone O; Burke MM; Rice A; Toquet C; Vernerey D; Frigo AC; Guillemain R; Pattier S; Smith J; Lota A; Potena L; Bontadini A; Ceccarelli C; Poli F; Feltrin G; Gerosa G; Manzan E; Thiene G; Bruneval P; Angelini A; Duong Van Huyen JP
Am J Transplant; 2015 Feb; 15(2):526-34. PubMed ID: 25612500
[TBL] [Abstract][Full Text] [Related]
19. Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy.
Moseley EL; Atkinson C; Sharples LD; Wallwork J; Goddard MJ
J Heart Lung Transplant; 2010 Apr; 29(4):417-23. PubMed ID: 20188594
[TBL] [Abstract][Full Text] [Related]
20. Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch.
Holt DB; Liapis H; Mohanakumar T; Phelan DR; Gandi SK; Huddleston CB; Canter CE
J Heart Lung Transplant; 2008 Oct; 27(10):1073-8. PubMed ID: 18926396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
